Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$509.44 -7.60 (-1.47%)
At close: Sep 29, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Common Equity (2010 - 2026)

Updated

Madrigal Pharmaceuticals' Common Equity was $523.72 million in Q2 2026, down 24.7% from $695.98 million a year earlier and down 3.6% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Common Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Madrigal Pharmaceuticals came in at $602.69 million, down 20.1% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • In earlier years, Common Equity was $754.38 million in FY2024 (+86.1%), $405.33 million in FY2023 (+105.3%), $197.39 million in FY2022 (+0.7%) and $196.11 million in FY2021 (-18.3%).
  • The Q2 2026 figure marks the lowest quarterly Common Equity since Q4 2023.
  • Compared with a year earlier, Common Equity has declined for six straight quarters, with an average decline of 5.3% over the last seven quarters.
  • The best year-over-year quarter for Common Equity over five years was Q2 2024 (growth of 728.1%); the worst was Q3 2022 (a decline of 95.5%).
  • Per Business Quant data, MDGL's Common Equity in the three quarters before Q2 2026 was $543.45 million (Q1 2026), $602.69 million (Q4 2025) and $625.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Madrigal Pharmaceuticals 15.07 Bn 11.32 Bn - 523.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 523.72 Mn
Mar 31, 2026 543.45 Mn
Dec 31, 2025 602.69 Mn
Sep 30, 2025 625.73 Mn
Jun 30, 2025 695.98 Mn
Mar 31, 2025 710.64 Mn
Dec 31, 2024 754.38 Mn
Sep 30, 2024 777.16 Mn
Jun 30, 2024 857.12 Mn
Mar 31, 2024 850.76 Mn
Dec 31, 2023 405.33 Mn
Sep 30, 2023 22.25 Mn
Jun 30, 2023 103.51 Mn
Mar 31, 2023 150.14 Mn
Dec 31, 2022 197.39 Mn
Sep 30, 2022 10.67 Mn
Jun 30, 2022 83.54 Mn
Mar 31, 2022 145.74 Mn
Dec 31, 2021 196.11 Mn
Sep 30, 2021 234.88 Mn
API Access

Madrigal Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MDGL&period=max&api_key=YOUR_API_KEY